ARCT

Arcturus Therapeutics Holdings (ARCT)

About Arcturus Therapeutics Holdings (ARCT)

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Details

Daily high

$7.36

Daily low

$6.92

Price at open

$7.16

52 Week High

$24.17

52 Week Low

$5.85

Market cap

206.0M

Dividend yield

0.00%

Volume

520,808

Avg. volume

865,566

P/E ratio

-2.94

Arcturus Therapeutics Holdings News